Endocyte Inc.
Funding rounds
2 counted as startup funding. Open the number of investors for the round's details.
| Month | Raised | Raise | Size | Investors | Sold | Filing |
|---|---|---|---|---|---|---|
| Dec 2010 | $8 M | No. 2 | $2 to $10 million | debt, options | SEC | |
| Aug 2009 | $27 M | No. 1 | $10 to $50 million | equity | SEC |
Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.
How it makes money#
What its filings and its own website say, sentence by sentence, each with its source.
Endocyte Inc. chose not to state its revenue in its newest notice of a funding round (Dec 2010).
SEC Form D · Dec 2010
The industry group it chose in its notices: Other.
SEC Form D · Dec 2010
That is all the official record says: Endocyte Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.
Products and services#
No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).
Investors#
16 named in official filings. Open an investor to see everything it has backed.
| Investor | Kind | Amount | Round | Role | Source |
|---|---|---|---|---|---|
| Cincinnati Financial Corp | Fund or asset manager | not stated | not stated | Held Series B, C-1, C-2 and C-3 preferred stock, 10% owner (Form 3, 2011) | SEC Form 3 |
| Douglas G. Bailey | Person | not stated | not stated | Held Series C-3 preferred stock, director (Form 3, 2011) | SEC Form 3 |
| John G. Clawson | Person | not stated | not stated | Held Series A-1 and C-3 preferred stock, director (Form 3, 2011) | SEC Form 3 |
| Pension Fund of the Christian Church (Disciples of Christ) Inc | Fund or asset manager | not stated | not stated | Held Series C-2 and C-3 preferred stock, 10% owner (Form 3, 2011) | SEC Form 3 |
| P. Ron Ellis | Person | not stated | not stated | Held Series A-1 preferred stock, director (Form 3, 2011) | SEC Form 3 |
| Sanderling V Beteiligungs Gmbh & Co KG | Company | not stated | not stated | Held Series B, C-1, C-2 and C-3 preferred stock, 10% owner (Form 3, 2011) | SEC Form 3 |
| Sanderling V Biomedical Co Investment Fund LP | Fund or asset manager | not stated | not stated | Held Series B, C-1, C-2 and C-3 preferred stock, 10% owner (Form 3, 2011) | SEC Form 3 |
| Sanderling V Biomedical LP | Fund or asset manager | not stated | not stated | Held Series B, C-1, C-2 and C-3 preferred stock, 10% owner (Form 3, 2011) | SEC Form 3 |
| Sanderling Venture Partners V Co Investment Fund, LP | Venture capital | not stated | not stated | Held Series B, C-1, C-2 and C-3 preferred stock, 10% owner (Form 3, 2011) | SEC Form 3 |
| Sanderling Venture Partners VI Co Investment Fund LP | Venture capital | not stated | not stated | Held Series B, C-1, C-2 and C-3 preferred stock, 10% owner (Form 3, 2011) | SEC Form 3 |
| Sanderling Venture Partners V, LP | Venture capital | not stated | not stated | Held Series B, C-1, C-2 and C-3 preferred stock, 10% owner (Form 3, 2011) | SEC Form 3 |
| Sanderling Ventures Management V | Venture capital | not stated | not stated | Held Series B, C-1, C-2 and C-3 preferred stock, 10% owner (Form 3, 2011) | SEC Form 3 |
| Sanderling Ventures Management VI | Venture capital | not stated | not stated | Held Series B, C-1, C-2 and C-3 preferred stock, 10% owner (Form 3, 2011) | SEC Form 3 |
| Sanderling VI Beteiligungs GmbH & Co KG | Company | not stated | not stated | Held Series B, C-1, C-2 and C-3 preferred stock, 10% owner (Form 3, 2011) | SEC Form 3 |
| Sanderling VI Limited Partnership | Fund or asset manager | not stated | not stated | Held Series B, C-1, C-2 and C-3 preferred stock, 10% owner (Form 3, 2011) | SEC Form 3 |
| Sanderling V LTD Partnership | Fund or asset manager | not stated | not stated | Held Series B, C-1, C-2 and C-3 preferred stock, 10% owner (Form 3, 2011) | SEC Form 3 |
Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 2 rounds above had up to 28 investors.
Executives and directors
As the company named them in its notices. Directors of a funded startup are often partners of its investors.
| Name | Role | Named in |
|---|---|---|
| Michael A. Sherman | Executive officer | Dec 2010 |
| P. Ron Ellis | Executive officer | Dec 2010 |
| Mike A. Sherman | Executive officer | Oct 2009 |
| Mike Sherman | Executive officer | Aug 2009 |
| Ann F. Hanham | Director | Dec 2010 |
| Douglas G. Bailey | Director | Dec 2010 |
| Fred A. Middleton | Director | Dec 2010 |
| James S. Shannon | Director | Dec 2010 |
| John C. Aplin | Director | Dec 2010 |
| John C. Clawson | Director | Dec 2010 |
| Keith E. Brauer | Director | Dec 2010 |
| P. Ron Ellis | Director | Dec 2010 |
| Philip S. Low | Director | Dec 2010 |
| Douglas B. Bailey | Director | Oct 2009 |
| Jack B. Clawson | Director | Oct 2009 |
| Keith B. Brauer | Director | Oct 2009 |
| Jack Clawson | Director | Aug 2009 |
| Keith Brauer | Director | Aug 2009 |